Skip to main content
. Author manuscript; available in PMC: 2021 May 27.
Published in final edited form as: Hepatology. 2020 Oct 22;72(6):2077–2089. doi: 10.1002/hep.31212

FIG. 1.

FIG. 1.

(A) At 8 weeks on the lithogenic diet, the prevalent rates of gallstones are 10% in OVX wild-type mice receiving no G-1, and most of these mice form solid cholesterol monohydrate crystals. The GPR30-selective agonist G-1 promotes gallstone formation in 80% of OVX wild-type and ERα−/− mice. Notably, only solid cholesterol monohydrate crystals, but not gallstones, are found in OVX GPR30−/− mice even treated with G-1 for 8 weeks. (B) Representative photomicrographs of solid plate-like cholesterol monohydrate crystals and gallstones as observed by polarizing light microscopy in gallbladder bile of OVX wild-type, GPR30−/−, and ERα−/− mice injected intramuscularly with G-1 at 0 or 1 μg/day and fed the lithogenic diet for 8 weeks. Magnifications are ×800 for left two panels and ×200 for right two panels.